Tonix Pharmaceuticals Holding Corp (NAS:TNXP)
$ 0.1755 0.001 (0.57%) Market Cap: 16.77 Mil Enterprise Value: 19.54 Mil PE Ratio: 0 PB Ratio: 0.12 GF Score: 34/100

Tonix Pharmaceuticals Holding Corp at Tarsier Capital Management Spring Summit Transcript

Mar 25, 2020 / 05:50PM GMT
Release Date Price: $148 (-25.25%)
Operator

Greetings, and welcome to the Tonix Pharmaceuticals Holding Corp. Spring Investor Summit webcast. It is now my pleasure to introduce your host, Seth Lederman, CEO of Tonix. Thank you, Mr. Lederman. You may begin.

Seth Lederman
Tonix Pharmaceuticals Holding Corp. - Co-Founder, CEO & Chairman

Well, thank you very much for the introduction, and thank you all for participating in this webcast. And I'm grateful to the organizers for rapidly converting this to an online conference in wake of the COVID pandemic.

I'm Seth Lederman. I'm the CEO of Tonix. And slide 2 is our forward-looking statement, disclaimer, and Safe Harbor statement. I want to specifically point out that we filed our 10-K after market yesterday. So there's very current information about the company on the SEC website in our annual report.

Slide 3 is just a very brief summary of our lead programs. We have the TNX-1800 potential vaccine for COVID, and that's in the preclinical stage. It's a live virus vaccine designed from our horse virus vaccine platform, and it expresses a

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot